Nomura Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,880
| Closed | -$950K | – | 1713 |
|
|
2023
Q2 | $950K | Sell |
22,880
-2,941
| -11% | -$122K | ﹤0.01% | 812 |
|
|
2023
Q1 | $1.55M | Buy |
25,821
+629
| +2% | +$37.8K | 0.01% | 747 |
|
|
2022
Q4 | $1.85M | Buy |
25,192
+2,754
| +12% | +$202K | 0.01% | 715 |
|
|
2022
Q3 | $1.7M | Buy |
22,438
+2,438
| +12% | +$185K | 0.01% | 702 |
|
|
2022
Q2 | $1.39M | Buy |
20,000
+2,400
| +14% | +$167K | 0.01% | 771 |
|
|
2022
Q1 | $1.46M | Hold |
17,600
| – | – | 0.01% | 789 |
|
|
2021
Q4 | $1.32M | Hold |
17,600
| – | – | 0.01% | 823 |
|
|
2021
Q3 | $2.04M | Buy |
17,600
+1,200
| +7% | +$139K | 0.01% | 703 |
|
|
2021
Q2 | $3.64M | Buy |
16,400
+1,200
| +8% | +$266K | 0.02% | 563 |
|
|
2021
Q1 | $2.01M | Buy |
15,200
+220
| +1% | +$29.1K | 0.01% | 713 |
|
|
2020
Q4 | $2.59M | Buy |
+14,980
| New | +$2.59M | 0.02% | 616 |
|